XML 97 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jul. 31, 2012
Jul. 31, 2011
Cash flow (used in) provided by operating activities:    
Net income (loss) $ 75,729 $ 24,752
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:    
Depreciation and amortization 16,523 17,123
Stock-based compensation 12,227 10,147
(Recovery) impairment of investment in unconsolidated entities (1,621) 39,600
Income from unconsolidated entities (17,727) (28,595)
Distributions of earnings from unconsolidated entities 4,028 7,315
Income from non-performing loan portfolios and foreclosed real estate (12,725) (1,187)
Deferred tax benefit 1,477 4,329
Deferred tax valuation allowances (1,477) (4,329)
Inventory impairments and write-offs 13,249 34,861
Change in fair value of mortgage loans receivable and derivative instruments (244) 628
Gain on marketable securities (40)   
Expenses related to early retirement of debt 0 3,414
Changes in operating assets and liabilities    
Increase in inventory (222,421) (208,204)
Origination of mortgage loans (434,780) (457,383)
Sale of mortgage loans 426,559 504,724
(Increase) decrease in restricted cash (27,248) 36,681
(Increase) decrease in receivables, prepaid expenses and other assets (22,175) (2,955)
Increase in customer deposits 41,777 18,090
Decrease in accounts payable and accrued expenses (58,865) (37,773)
Decrease in income tax refund recoverable    141,590
Decrease in income taxes payable (26,342) (56,461)
Net cash (used in) provided by operating activities (234,096) 46,367
Cash flow used in investing activities:    
Purchase of property and equipment - net (7,318) (6,927)
Purchase of marketable securities (317,569) (420,087)
Sale and redemption of marketable securities 270,503 318,372
Investment in and advances to unconsolidated entities (195,813)   
Return of investments in unconsolidated entities 33,231 26,285
Investment in non-performing loan portfolios and foreclosed real estate (30,090) (42,141)
Return of investments in non-performing loan portfolios and foreclosed real estate 14,412 101
Acquisition of a business (144,746)   
Net cash used in investing activities (377,390) (124,397)
Cash flow provided by (used in) financing activities:    
Net proceeds from issuance of senior notes 296,227   
Proceeds from loans payable 675,481 666,659
Principal payments of loans payable (689,242) (715,131)
Redemption of senior notes    (48,437)
Proceeds from stock-based benefit plans 24,515 23,731
Receipts related to noncontrolling interest    2,678
Purchase of treasury stock (384) (463)
Net cash provided by (used in) financing activities 306,597 (70,963)
Net decrease in cash and cash equivalents (304,889) (148,993)
Cash and cash equivalents, beginning of period 906,340 1,039,060
Cash and cash equivalents, end of period $ 601,451 $ 890,067